Voyager Therapeutics Inc (VYGR)
7.62
+0.20
(+2.70%)
USD |
NASDAQ |
Apr 26, 16:00
7.62
0.00 (0.00%)
After-Hours: 20:00
Voyager Therapeutics Enterprise Value: 182.90M for April 26, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 26, 2024 | 182.90M |
| April 25, 2024 | 172.04M |
| April 24, 2024 | 180.18M |
| April 23, 2024 | 184.52M |
| April 22, 2024 | 180.18M |
| April 19, 2024 | 176.38M |
| April 18, 2024 | 179.09M |
| April 17, 2024 | 189.41M |
| April 16, 2024 | 202.44M |
| April 15, 2024 | 216.56M |
| April 12, 2024 | 226.88M |
| April 11, 2024 | 245.88M |
| April 10, 2024 | 248.60M |
| April 09, 2024 | 262.72M |
| April 08, 2024 | 261.09M |
| April 05, 2024 | 275.75M |
| April 04, 2024 | 264.89M |
| April 03, 2024 | 276.84M |
| April 02, 2024 | 307.24M |
| April 01, 2024 | 341.45M |
| March 28, 2024 | 274.66M |
| March 27, 2024 | 288.24M |
| March 26, 2024 | 313.22M |
| March 25, 2024 | 271.95M |
| March 22, 2024 | 258.37M |
| Date | Value |
|---|---|
| March 21, 2024 | 279.55M |
| March 20, 2024 | 331.14M |
| March 19, 2024 | 315.39M |
| March 18, 2024 | 262.72M |
| March 15, 2024 | 273.03M |
| March 14, 2024 | 264.89M |
| March 13, 2024 | 265.43M |
| March 12, 2024 | 262.72M |
| March 11, 2024 | 261.09M |
| March 08, 2024 | 277.92M |
| March 07, 2024 | 281.72M |
| March 06, 2024 | 270.32M |
| March 05, 2024 | 263.26M |
| March 04, 2024 | 292.58M |
| March 01, 2024 | 281.72M |
| February 29, 2024 | 220.91M |
| February 28, 2024 | 256.20M |
| February 27, 2024 | 252.94M |
| February 26, 2024 | 238.28M |
| February 23, 2024 | 213.30M |
| February 22, 2024 | 187.78M |
| February 21, 2024 | 183.98M |
| February 20, 2024 | 189.95M |
| February 16, 2024 | 188.84M |
| February 15, 2024 | 196.62M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-38.66M
Minimum
Sep 29 2021
710.15M
Maximum
Jul 03 2019
149.61M
Average
124.55M
Median
Aug 09 2023
Enterprise Value Benchmarks
| Biogen Inc | 35.88B |
| United Therapeutics Corp | 8.711B |
| MEI Pharma Inc | -39.16M |
| Macrogenics Inc | 679.20M |
| Moderna Inc | 32.74B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 56.40M |
| Revenue (Quarterly) | 90.06M |
| Total Expenses (Quarterly) | 36.00M |
| EPS Diluted (Quarterly) | 1.19 |
| Profit Margin (Quarterly) | 62.62% |
| Earnings Yield | 39.76% |
| Operating Earnings Yield | 35.58% |
| Normalized Earnings Yield | 39.76 |